Target intelligence / Profile preview

Death-associated protein-like 1 (DAPL1)

Target
DAPL1
Molecular classification
Other (putative regulator of epithelial differentiation; not a classical receptor, enzyme, ion channel, transporter, or transcription factor)
01

Overview

Death-associated protein-like 1 (DAPL1) is a protein primarily involved in the regulation of epithelial cell homeostasis, differentiation, and apoptosis. It is highly expressed in tissues such as the retina/RPE, testis, and other epithelial linings. DAPL1 functions as a negative regulator of cell proliferation, and loss of DAPL1 leads to abnormal epithelial growth and disrupted tissue organization, as seen in knockout mouse models. In the testes, DAPL1 regulates steroidogenic pathways by influencing the expression of enzymes and factors controlling testosterone synthesis. Genomic variants in the DAPL1 locus are associated with increased susceptibility to age-related macular degeneration, especially in females. At present, DAPL1 is emerging as a disease-associated gene and a potential biomarker but is not yet a direct therapeutic target for drugs[1][3][4][5][6][7].

Other names
Early epithelial differentiation-associated proteinEEDAdeath associated protein like 1Death Associated Protein Like 1DAPL1
02

Biological functions

Regulation of epithelial cell proliferationApoptosis (cell death)Epithelial differentiationCellular homeostasisRegulation of steroidogenesis in Leydig cellsNegative regulation of T cell activation
03

Disease associations

Age-related macular degeneration (AMD)Oral cancerVitiligoCataractPotential role in other epithelial disorders
04

Safety considerations

Disruption may affect epithelial integrity and differentiation[3][4]Implication in testicular steroidogenesis and testosterone regulation[5]
05

Biomarkers

Potential biomarker for age-related macular degeneration susceptibility (SNPs in DAPL1 locus)[1]Modulator of epithelial homeostasis in RPE (retinal pigment epithelium)[3]Potential biomarker in oral cancer and vitiligo[3]

Beyond the preview

Go deeper on Death-associated protein-like 1 (DAPL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Death-associated protein-like 1 (DAPL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call